Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis

Figure 3

Clinical correlation diagram in patients with MG. (a) Linear correlations between the concentration of AchR-Ab and the expression of OX40 on CD4⁺ T cells in MG patients in relapse. (b) Linear correlations between the disease duration and the expression of OX40L on CD19⁺ T cells in MG patients in relapse. (c) Linear correlations between the disease duration and the expression of OX40L on CD14⁺ mononuclear cells in MG patients in relapse. (d) Comparison of sOX40 expression levels in plasma before and after immunosuppressive therapy in 13 MG patients with relapse. (e) Comparison of sOX40L expression levels in plasma before and after immunosuppressive therapy in 13 MG patients with relapse.

(a)

(b)

(c)

(d)

(e)